Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis.
Hoang Nam PhamLinh PhamKeisaku Sato
Published in: Expert opinion on pharmacotherapy (2024)
Only vancomycin demonstrated promising therapeutic effects in the phase III clinical trial. Other drug candidates showed futility or inconsistent results, and the search for novel PSC treatments is still ongoing.